杰克说药 | GPP治疗新突破：佩索利单抗与IL-36靶点的未来
Spesolimab的获批，代表IL-36靶点在抗体类型药物的突破。
Time：
2023-06-27 11:40
Author：
李杰教授
Recommended content
WCLC 2026 | Hansun "Blows the Roof Off", the New King of B7-H3 ADC is About to be Crowned
It's time for Chinese innovative drugs to redefine the standards.
mRNA tumor vaccine "seller", entering a golden age
When a Biotech company that has been acquired achieves rare growth
AI、 Cold bench and puzzle, when will 'one person, one seedling' come to an end?
This road is long, but the threshold has already been crossed.
The "economic accounts" of immunology business development are being rewritten
联系我们
同写意
写意宣发
同写意Biotech
同写意微服务